The Antiproliferative Potential and Mechanism of Action of Metformin in MCF-7 Cells

References

• BodmerM , MeierC , KrahenbuhlS , JickSS , MeierCR. Long-term metformin use is associated with decreased risk of breast cancer. Diabetes Care33(6), 1304–1308 (2010).
   PubMed Web of Science ®Google Scholar
• EvansJM , DonnellyLA , Emslie-SmithAM , AlessiDR , MorrisAD. Metformin and reduced risk of cancer in diabetic patients. Brit. Med. J.330(7503), 1304–1305 (2005).
   PubMed Web of Science ®Google Scholar
• AljofanM , GaipovA. Metformin: a stroke of luck. Electron J. Gen. Med.16(3), em143 (2019).
   Web of Science ®Google Scholar
• SchneiderMB , MatsuzakiH , HaorahJet al.Prevention of pancreatic cancer induction in hamsters by metformin. Gastroenterology120(5), 1263–1270 (2001).
   PubMed Web of Science ®Google Scholar
• LibbyG , DonnellyLA , DonnanPT , AlessiDR , MorrisAD , EvansJMM. New Users of Metformin Are at Low Risk of Incident Cancer A cohort study among people with Type 2 diabetes. Diabetes Care32(9), 1620–1625 (2009).
   PubMed Web of Science ®Google Scholar
• BowkerSL , MajumdarSR , VeugelersP , JohnsonJA. Increased cancer-related mortality for patients with Type 2 diabetes who use sulfonylureas or insulin – Response to Farooki and Schneider. Diabetes Care29(8), 1990–1991 (2006).
   PubMed Web of Science ®Google Scholar
• Druesne-PecolloN , TouvierM , BarrandonEet al.Excess body weight and second primary cancer risk after breast cancer: a systematic review and meta-analysis of prospective studies. Breast Cancer Res. Treat.135(3), 647–654 (2012).
   PubMed Web of Science ®Google Scholar
• AljofanM , RiethmacherD. Anticancer activity of metformin: a systematic review of the literature. Future Sci. OA5(8), FSO410 (2019) .
   PubMed Web of Science ®Google Scholar
• HuangX , WullschlegerS , ShpiroNet al.Important role of the LKB1-AMPK pathway in suppressing tumorigenesis in PTEN-deficient mice. Biochem. J.412, 211–221 (2008).
   PubMed Web of Science ®Google Scholar
• TriggleCR , MohammedI , BsheshKet al.Metformin: is it a drug for all reasons and diseases?Metabolism133, 155223 (2022).
   PubMed Web of Science ®Google Scholar
• ZakikhaniM , DowlingR , FantusIG , SonenbergN , PollakM. Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells. Cancer Res.66(21), 10269–10273 (2006).
   PubMed Web of Science ®Google Scholar
• KinaanM , DingH , TriggleCR. Metformin: An Old Drug for the Treatment of Diabetes but a New Drug for the Protection of the Endothelium. Med. Prin. Pract.24(5), 401–415 (2015).
   PubMed Web of Science ®Google Scholar
• SamuelSM , GhoshS , MajeedYet al.Metformin represses glucose starvation induced autophagic response in microvascular endothelial cells and promotes cell death. Biochem. Pharmacol.132, 118–132 (2017).
   PubMed Web of Science ®Google Scholar
• MarinelloPC , da SilvaTN , PanisCet al.Mechanism of metformin action in MCF-7 and MDA-MB-231 human breast cancer cells involves oxidative stress generation, DNA damage, and transforming growth factor beta1 induction. Tumour Biol.37(4), 5337–5346 (2016).
   PubMedGoogle Scholar
• LiuJ , HouM , YuanTet al.Enhanced cytotoxic effect of low doses of metformin combined with ionizing radiation on hepatoma cells via ATP deprivation and inhibition of DNA repair. Oncol. Rep.28(4), 1406–1412 (2012).
   PubMed Web of Science ®Google Scholar
• YangZNJ , CheeCE , HuangSB , SinicropeFA. The role of autophagy in cancer: therapeutic implications. Mol. Cancer Ther.10(9), 1533–1541 (2011).
   PubMed Web of Science ®Google Scholar
• LevyJMM , ThorburnA. Autophagy in cancer: moving from understanding mechanism to improving therapy responses in patients. Cell Death Differ.27(3), 843–857 (2020).
   PubMed Web of Science ®Google Scholar
• BhatP , KrielJ , ShubhaPriya B , Basappa , ShivananjuNS , LoosB. Modulating autophagy in cancer therapy: advancements and challenges for cancer cell death sensitization. Biochem. Pharmacol.147, 170–182 (2018).
   PubMed Web of Science ®Google Scholar
• QuXP , YuJ , BhagatGet al.Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. J. Clin. Invest.112(12), 1809–1820 (2003).
   PubMed Web of Science ®Google Scholar
• LiYH , HahnT , GarrisonKet al.The vitamin E analogue alpha-TEA stimulates tumor autophagy and enhances antigen cross-presentation. Cancer Res.72(14), 3535–3545 (2012).
   PubMed Web of Science ®Google Scholar
• MagawayC , KimE , JacintoE. Targeting mTOR and metabolism in cancer: lessons and innovations. Cell8(12), (2019).
   PubMed Web of Science ®Google Scholar
• BlommaartEFC , KrauseU , SchellensJPM , VreelingSindelarovaH , MeijerAJ. The phosphatidylinositol 3-kinase inhibitors wortmannin and LY294002 inhibit autophagy in isolated rat hepatocytes. Eur. J. Biochem.243(1–2), 240–246 (1997).
   PubMedGoogle Scholar
• RoachPJ. AMPK -> ULK1 -> Autophagy. Mol. Cell. Biol.31(15), 3082–3084 (2011).
   PubMed Web of Science ®Google Scholar
• BudanovAV , KarinM. p53 target genes sestrin1 and sestrin2 connect genotoxic stress and mTOR signaling (vol 134, pg 451, 2008). Cell136(2), 378 (2009).
   Web of Science ®Google Scholar
• FengZ , ZhangH , LevineAJ , JinS. The coordinate regulation of the p53 and mTOR pathways in cells. Proc. Natl Acad. Sci. USA102(23), 8204–8209 (2005).
   PubMed Web of Science ®Google Scholar
• TanM , WuA , LiaoNet al.Inhibiting ROS-TFE3-dependent autophagy enhances the therapeutic response to metformin in breast cancer. Free Radic. Res.52(8), 872–886 (2018).
   PubMed Web of Science ®Google Scholar
• AminS , LuxA , O'CallaghanF. The journey of metformin from glycaemic control to mTOR inhibition and the suppression of tumour growth. Br. J. Clin. Pharmacol.85(1), 37–46 (2019).
   PubMed Web of Science ®Google Scholar
• TianT , LiX , ZhangJ. mTOR signaling in cancer and mTOR inhibitors in solid tumor targeting therapy. Int. J. Mol. Sci.20(3), 755 (2019).
   PubMed Web of Science ®Google Scholar
• ShintaniT , KlionskyDJ. Autophagy in health and disease: a double-edged sword. Science306(5698), 990–995 (2004).
   PubMed Web of Science ®Google Scholar
• ZouZ , TaoT , LiH , ZhuX. mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges. Cell Biosci.10, 31 (2020).
   PubMed Web of Science ®Google Scholar
• JonesAT. Macropinocytosis: searching for an endocytic identity and role in the uptake of cell penetrating peptides. J. Cell. Mol. Med.11(4), 670–684 (2007).
   PubMed Web of Science ®Google Scholar
• EngelmanJA. Targeting PI3K signalling in cancer: opportunities, challenges and limitations. Nat. Rev. Cancer9(8), 550–562 (2009).
   PubMed Web of Science ®Google Scholar